Memorial Sloan Kettering Cancer Center

Locations: 🇺🇸
Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California, United States
🇺🇸
Children's Healthcare of Atlanta (Data Collection and Specimen Analysis), Atlanta, Georgia, United States
🇺🇸
Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States

and more 8 locations

A Registry for People With T-cell Lymphoma

Recruiting

Conditions: Chronic Lymphoproliferative Disorder of NK Cells
Aggressive NK-cell Leukemia
Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)
Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood
Extranodal NK/T-cell Lymphoma, Nasal Type
Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
Mycosis Fungoides
Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
T-cell Lymphoma
Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form

Interventions: Other: Optional Blood Sample and Nail Sample

First Posted Date: 2023-08-07

Last Posted Date: 2024-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1000

Registration Number: NCT05978141

Locations: 🇺🇸
Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States
🇺🇸
University of Miami (Data Collection Only), Miami, Florida, United States
🇺🇸
University of Nebraska (Data collection only), Omaha, Nebraska, United States

and more 23 locations

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: Benralizumab
Drug: fulvestrant or AIs) and PI3K inhibition (alpelisib)

First Posted Date: 2023-07-28

Last Posted Date: 2024-08-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1

Registration Number: NCT05966584

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia

Recruiting

Conditions: Anesthesia

Interventions: Diagnostic Test: Echocardiography

First Posted Date: 2023-07-20

Last Posted Date: 2024-06-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 250

Registration Number: NCT05954832

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All protocol activites), New York, New York, United States

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Not Applicable

Recruiting

Conditions: Lymphoma
Large-cell Lymphoma
Large B-cell Lymphoma
Mediastinal B-Cell Diffuse Large Cell Lymphoma
Lymphoma, B-Cell
DLBCL - Diffuse Large B Cell Lymphoma

Interventions: Behavioral: Hematolo-GIST Training
Behavioral: Participants Appointment

First Posted Date: 2023-07-11

Last Posted Date: 2024-10-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 48

Registration Number: NCT05940272

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All protocol activities), New York, New York, United States
🇺🇸
NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York, New York, United States
🇺🇸
Weill Cornell Medical College (Data analysis only), New York, New York, United States

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Not Applicable

Withdrawn

Conditions: Glioblastoma

Interventions: Diagnostic Test: Lumber Puncture

First Posted Date: 2023-07-03

Last Posted Date: 2024-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT05927610

A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

Phase 2

Recruiting

Conditions: Melanoma

Interventions: Drug: IO102/IO103
Drug: Nivolumab-Relatlimab

First Posted Date: 2023-06-22

Last Posted Date: 2024-08-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 43

Registration Number: NCT05912244

Locations: 🇺🇸
Hartford Healthcare Alliance (Data Collection Only), Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

and more 6 locations

A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer

Not Applicable

Recruiting

Conditions: Improve Sexual Health
Improve Vulvovaginal Health

Interventions: Other: questionnaires
Other: moisturizers

First Posted Date: 2023-06-18

Last Posted Date: 2024-07-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT05910294

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 4 locations

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

Phase 2

Recruiting

Conditions: Metastatic Breast Cancer

Interventions: Drug: Tucatinib

First Posted Date: 2023-06-07

Last Posted Date: 2024-08-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT05892068

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Home Terms & Conditions Privacy Policy